Industry news that matters to you.  Learn more

Archives for December 2010

Biomarker Database Startup GnuBio Raises $3M

Earlier this month, Harvard University spinout GnuBio Inc. raised $3 million in an equity offering filed with the U.S. Securities and Exchange Commission. The company, founded by John Boyce, promises to join together millions of biological samples siloed at institutes around the world using an open source platform.

23andMe Receives NIH Funding to Evaluate Web-Based Research on the Genetics of Drug Response

Genetic testing company 23andMe announced last week the launch of a project that aims to use web surveys to improve personalized medicine. The project, supported by the National Institutes of Health (NIH), plans to validate 23andMe’s highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for “Web-based Phenotyping for Genome-Wide Association Studies of Drug Response” from NIH’s National Human Genome Research Institute (NHGRI).

Trophos to Lead MitoCare Consortium for Study of Cardioprotective Compound

Trophos SA, a clinical stage pharmaceutical company based in Marseille, France that develops innovative therapeutics for indications with under-served needs in neurology and cardiology, announced last week a European Union award of €6 million to support MitoCare, a 2.5 year international, translational medicine project.

Philips and Definiens to Jointly Develop Digital Pathology System

Royal Philips Electronics and Definiens have signed an agreement to jointly develop a digital pathology system. The system will support the clinical diagnosis of several types of cancer, starting with breast cancer.

DiaGenic and Pfizer to Collaborate on Early Stage Alzheimer’s Disease Biomarkers

DiaGenic and Pfizer today signed an agreement for an explorative research and development collaboration to identify blood-based biomarkers in early stages of Alzheimer’s disease (AD).